PubRank

Masanobu Usui

Author PubWeight™ 31.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology 2008 1.86
2 Human equilibrative nucleoside transporter 1 expression is a strong independent prognostic factor in UICC T3-T4 pancreatic cancer patients treated with preoperative gemcitabine-based chemoradiotherapy. J Hepatobiliary Pancreat Sci 2012 1.20
3 Pancreaticoduodenectomy with resection of the splenic artery and splenectomy for pancreatic double cancers after total gastrectomy. Preservation of the pancreatic function via the blood supply from the posterior epiploic artery: report of a case. Surg Today 2011 0.98
4 Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system. J Hepatobiliary Pancreat Sci 2009 0.93
5 Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study. J Gastroenterol Hepatol 2007 0.88
6 Clinical features and treatment outcome of borderline resectable pancreatic head/body cancer: a multi-institutional survey by the Japanese Society of Pancreatic Surgery. J Hepatobiliary Pancreat Sci 2013 0.88
7 Monitoring peripheral blood CD4+ adenosine triphosphate activity after living donor liver transplantation: impact of combination assays of immune function and CYP3A5 genotype. J Hepatobiliary Pancreat Sci 2011 0.87
8 Hemostatic abnormalities and liver diseases. Semin Thromb Hemost 2009 0.85
9 Activated protein C prevents hepatic ischaemia-reperfusion injury in rats. Liver Int 2008 0.85
10 A standardized technique for safe pancreaticojejunostomy: Pair-Watch suturing technique. World J Gastrointest Surg 2010 0.84
11 Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma: significance of the CA19-9 reduction rate and intratumoral human equilibrative nucleoside transporter 1 expression. Pancreas 2014 0.84
12 Impact of CYP3A5 genotype of recipients as well as donors on the tacrolimus pharmacokinetics and infectious complications after living-donor liver transplantation for Japanese adult recipients. Ann Transplant 2012 0.84
13 Benefit of technetium-99m galactosyl human serum albumin scintigraphy instead of indocyanine green test in patients scheduled for hepatectomy. Hepatol Res 2014 0.83
14 Impact of venous drainage on regeneration of the anterior segment of right living-related liver grafts. Clin Transplant 2006 0.83
15 Total vascular hepatic exclusion for tumor resection: a new approach to the intrathoracic inferior vena cava through the abdominal cavity by cutting the diaphragm vertically without cutting the pericardium. J Hepatobiliary Pancreat Sci 2010 0.81
16 Assessment of liver graft function and regeneration by galactosyl-human serum albumin (99mTc-GSA) liver scintigraphy in adult living-donor liver transplantation. Clin Transplant 2009 0.81
17 Prospective study on the outcome of patients with hepatocellular carcinoma registered for living donor liver transplantation: how long can they wait? Transplantation 2010 0.81
18 Anterior approach to the superior mesenteric artery by using nerve plexus hanging maneuver for borderline resectable pancreatic head carcinoma. J Gastrointest Surg 2014 0.80
19 Paradoxical impact of the remnant pancreatic volume and infectious complications on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci 2014 0.80
20 Proposal for a morphological classification of intraductal papillary neoplasm of the bile duct (IPN-B). J Hepatobiliary Pancreat Sci 2013 0.80
21 Elevated fibrin-related markers in patients with malignant diseases frequently associated with disseminated intravascular coagulation and venous thromboembolism. Intern Med 2014 0.80
22 Successful laparoscopic splenectomy after living-donor liver transplantation for thrombocytopenia caused by antiviral therapy. World J Gastroenterol 2008 0.80
23 Elevated fibrin-related markers in patients with malignant diseases suspected of having thrombotic disorders. Clin Appl Thromb Hemost 2009 0.79
24 Dual cytoprotective effects of splenectomy for small-for-size liver transplantation in rats. Liver Transpl 2012 0.79
25 The cytoprotective effects of addition of activated protein C into preservation solution on small-for-size grafts in rats. Liver Transpl 2010 0.79
26 Stent placement for portal venous stenosis following major abdominal surgery. Hepatogastroenterology 2009 0.78
27 Maximizing venous outflow after right hepatic living donor liver transplantation with a venous graft patch. Dig Surg 2008 0.78
28 Immunological aspects in late phase of living donor liver transplant patients: usefulness of monitoring peripheral blood CD4+ adenosine triphosphate activity. Clin Dev Immunol 2013 0.78
29 The effectiveness of measuring for fragmented red cells using an automated hematology analyzer in patients with thrombotic microangiopathy. Clin Appl Thromb Hemost 2008 0.78
30 Decreased ADAMTS13 levels in patients after living donor liver transplantation. Thromb Res 2009 0.78
31 Impact of histological response after neoadjuvant chemoradiotherapy on recurrence-free survival in UICC-T3 pancreatic adenocarcinoma but not in UICC-T4. Pancreas 2012 0.77
32 The impact of total bilirubin on plasma micafungin levels in living-donor liver transplantation recipients with severe liver dysfunction. Biol Pharm Bull 2009 0.77
33 Functional independence measure scores predict level of long-term care required by patients after stroke: a multicenter retrospective cohort study. Disabil Rehabil 2014 0.77
34 Splenectomy increases the number of circulating hematopoietic stem/progenitor cells in patients with hepatitis C virus-associated liver cirrhosis. Hepatol Res 2014 0.77
35 Stent-graft for the management of hepatic artery rupture subsequent to transcatheter thrombolysis and angioplasty in a liver transplant recipient. Cardiovasc Intervent Radiol 2007 0.76
36 Behavior of ADAMTS13 and Von Willebrand factor levels in patients after living donor liver transplantation. Thromb Res 2012 0.76
37 A Novel Predictor of Posttransplant Portal Hypertension in Adult-To-Adult Living Donor Liver Transplantation: Increased Estimated Spleen/Graft Volume Ratio. Transplantation 2016 0.75
38 Human Equilibrative Nucleoside Transporter 1 Expression in Endoscopic Ultrasonography-Guided Fine-Needle Aspiration Biopsy Samples Is a Strong Predictor of Clinical Response and Survival in the Patients With Pancreatic Ductal Adenocarcinoma Undergoing Gemcitabine-Based Chemoradiotherapy. Pancreas 2016 0.75
39 Combination assays for evaluation of immune function and CYP3A5 genotype to identify the risk of infectious complications and mortality in living donor liver transplant patients. Ann Transplant 2013 0.75
40 Negative Impact of Biliary Candidiasis on Early and Late Postoperative Complications After Pancreatoduodenectomy Usefulness of the CHROMagar Candida Plate for Identification. Pancreas 2016 0.75
41 [Studies on the distribution of doripenem in pancreatic tissues, especially on the importance of the ratio in pancreatic tissue concentration of doripenem/serum concentration of doripenem]. Jpn J Antibiot 2014 0.75
42 Use of an interpositional venous graft posterior to the pancreas for LDLT patients with portal vein thrombosis. Hepatogastroenterology 2007 0.75
43 [Analysis of platelet production following liver transplantation using the immature platelet fraction (IPF) parameter]. Rinsho Byori 2008 0.75
44 An approach to the intra-thoracic inferior vena cava through the abdominal cavity preparing for total hepatic vascular exclusion by sagittal diaphragmotomy. Hepatogastroenterology 2013 0.75
45 Incidence and Risk Factors of Postoperative Delirium following Pancreatic Surgery: Does the Administration of TJ-54 Reduce the Incidence of Delirium? Dig Surg 2017 0.75
46 Prolonged thrombocytopenia after living donor liver transplantation is a strong prognostic predictor irrespective of splenectomy: the significance of ADAMTS13 and graft function [corrected]. Int J Hematol 2014 0.75